{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:20:25Z","timestamp":1792815625569,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2010,6,28]],"date-time":"2010-06-28T00:00:00Z","timestamp":1277683200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s10067-010-1526-z","type":"journal-article","created":{"date-parts":[[2010,6,27]],"date-time":"2010-06-27T05:59:39Z","timestamp":1277618379000},"page":"1031-1035","source":"Crossref","is-referenced-by-count":46,"title":["B-lymphocyte activating factor levels are increased in patients with Wegener\u2019s granulomatosis and inversely correlated with ANCA titer"],"prefix":"10.1007","volume":"29","author":[{"given":"Lucius","family":"Bader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenche","family":"Koldingsnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Nossent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,28]]},"reference":[{"issue":"2","key":"1526_CR1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/ard.60.2.170","volume":"60","author":"RA Watts","year":"2001","unstructured":"Watts RA, Gonzalez-Gay MA, Lane SE, Garcia-Porrua C, Bentham G, Scott DG (2001) Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe. Ann Rheum Dis 60(2):170\u2013172","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1526_CR2","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/1529-0131(200011)43:11<2481::AID-ANR15>3.0.CO;2-6","volume":"43","author":"W Koldingsnes","year":"2000","unstructured":"Koldingsnes W, Nossent H (2000) Epidemiology of Wegener\u2019s granulomatosis in northern Norway. Arthritis Rheum 43(11):2481\u20132487","journal-title":"Arthritis Rheum"},{"key":"1526_CR3","author":"N Basu","year":"2010","unstructured":"Basu N, Watts R, Bajema I, Baslund B, Bley T, Boers M et al (2010) EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis. doi: 10.1136\/ard.2009.119032","journal-title":"Ann Rheum Dis."},{"issue":"Suppl 2","key":"1526_CR4","first-page":"SII51","volume":"69","author":"GA Preston","year":"2002","unstructured":"Preston GA, Yang JJ, Xiao H, Falk RJ (2002) Understanding the pathogenesis of ANCA: where are we today? Clevel Clin J Med 69(Suppl 2):SII51\u2013SII54","journal-title":"Clevel Clin J Med"},{"issue":"10","key":"1526_CR5","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2169\/internalmedicine.38.759","volume":"38","author":"E Csernok","year":"1999","unstructured":"Csernok E, Muller A, Gross WL (1999) Immunopathology of ANCA-associated vasculitis. Intern Med 38(10):759\u2013765","journal-title":"Intern Med"},{"issue":"1 Suppl 44","key":"1526_CR6","first-page":"S57","volume":"25","author":"RA Luqmani","year":"2007","unstructured":"Luqmani RA (2007) Towards diagnostic criteria for the ANCA-associated vasculitides. Clin Exp Rheumatol 25(1 Suppl 44):S57","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"1526_CR7","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/rheumatology\/kem146a","volume":"46","author":"C Lapraik","year":"2007","unstructured":"Lapraik C, Watts R, Bacon P, Carruthers D, Chakravarty K, D\u2019Cruz D et al (2007) BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford) 46(10):1615\u20131616","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1526_CR8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ndt\/gfn430","volume":"24","author":"S Lovric","year":"2009","unstructured":"Lovric S, Erdbruegger U, Kumpers P, Woywodt A, Koenecke C, Wedemeyer H et al (2009) Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients. Nephrol Dial Transplant 24(1):179\u2013185","journal-title":"Nephrol Dial Transplant"},{"key":"1526_CR9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1196\/annals.1423.028","volume":"1110","author":"P Lamprecht","year":"2007","unstructured":"Lamprecht P, Till A, Steinmann J, Aries PM, Gross WL (2007) Current state of biologicals in the management of systemic vasculitis. Ann NY Acad Sci 1110:261\u2013270","journal-title":"Ann NY Acad Sci"},{"issue":"8","key":"1526_CR10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nrrheum.2009.141","volume":"5","author":"T Dorner","year":"2009","unstructured":"Dorner T, Radbruch A, Burmester GR (2009) B-cell-directed therapies for autoimmune disease. Nat Rev Rheumatol 5(8):433\u2013441","journal-title":"Nat Rev Rheumatol"},{"key":"1526_CR11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev.immunol.21.120601.141152","volume":"21","author":"F Mackay","year":"2003","unstructured":"Mackay F, Schneider P, Rennert P, Browning J (2003) BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol 21:231\u2013264","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"1526_CR12","first-page":"31","volume":"55","author":"K Groot De","year":"2001","unstructured":"De Groot K, Gross WL, Herlyn K, Reinhold-Keller E (2001) Development and validation of a disease extent index for Wegener\u2019s granulomatosis. Clin Nephrol 55(1):31\u201338","journal-title":"Clin Nephrol"},{"issue":"11","key":"1526_CR13","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1084\/jem.189.11.1747","volume":"189","author":"P Schneider","year":"1999","unstructured":"Schneider P, Mackay F, Steiner V, Hofmann K, Bodmer JL, Holler N et al (1999) BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189(11):1747\u20131756","journal-title":"J Exp Med"},{"issue":"7","key":"1526_CR14","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nri844","volume":"2","author":"F Mackay","year":"2002","unstructured":"Mackay F, Browning JL (2002) BAFF: a fundamental survival factor for B cells. Nat Rev Immunol 2(7):465\u2013475","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"1526_CR15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jaut.2005.08.004","volume":"25","author":"M Krumbholz","year":"2005","unstructured":"Krumbholz M, Specks U, Wick M, Kalled SL, Jenne D, Meinl E (2005) BAFF is elevated in serum of patients with Wegener\u2019s granulomatosis. J Autoimmun 25(4):298\u2013302","journal-title":"J Autoimmun"},{"issue":"11","key":"1526_CR16","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1136\/ard.2005.046219","volume":"65","author":"JS Sanders","year":"2006","unstructured":"Sanders JS, Huitma MG, Kallenberg CG, Stegeman CA (2006) Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapse. Ann Rheum Dis 65(11):1484\u20131489","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1526_CR17","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1177\/0961203306071871","volume":"15","author":"A Becker-Merok","year":"2006","unstructured":"Becker-Merok A, Nikolaisen C, Nossent HC (2006) B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time. Lupus 15(9):570\u2013576","journal-title":"Lupus"},{"issue":"7","key":"1526_CR18","first-page":"1256","volume":"35","author":"S Bosello","year":"2008","unstructured":"Bosello S, Youinou P, Daridon C, Tolusso B, Bendaoud B, Pietrapertosa D et al (2008) Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis. J Rheumatol 35(7):1256\u20131264","journal-title":"J Rheumatol"},{"issue":"3","key":"1526_CR19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/ar755","volume":"5","author":"W Stohl","year":"2003","unstructured":"Stohl W (2003) SLE\u2013systemic lupus erythematosus: a BLySful, yet BAFFling, disorder. Arthritis Res Ther 5(3):136\u2013138","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"1526_CR20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0950-3579(97)80052-0","volume":"11","author":"RA Luqmani","year":"1997","unstructured":"Luqmani RA, Exley AR, Kitas GD, Bacon PA (1997) Disease assessment and management of the vasculitides. Bailli\u00e8res Clin Rheumatol 11(2):423\u2013446","journal-title":"Bailli\u00e8res Clin Rheumatol"},{"key":"1526_CR21","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","volume":"68","author":"C Mukhtyar","year":"2008","unstructured":"Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S et al (2008) Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 68:1827\u20131832. doi: 10.1136\/ard.2008.101279","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1526_CR22","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/art.1780400222","volume":"40","author":"AR Exley","year":"1997","unstructured":"Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage CO et al (1997) Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 40(2):371\u2013380","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1526_CR23","first-page":"482","volume":"29","author":"R Omdal","year":"2002","unstructured":"Omdal R, Mellgren SI, Koldingsnes W, Jacobsen EA, Husby G (2002) Fatigue in patients with systemic lupus erythematosus: lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics. J Rheumatol 29(3):482\u2013486","journal-title":"J Rheumatol"},{"issue":"7","key":"1526_CR24","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1681\/ASN.V1371977","volume":"13","author":"RJ Falk","year":"2002","unstructured":"Falk RJ, Jennette JC (2002) ANCA are pathogenic \u2014oh yes they are! J Am Soc Nephrol 13(7):1977\u20131979","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"1526_CR25","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/rheumatology\/ken246","volume":"47","author":"JC Nossent","year":"2008","unstructured":"Nossent JC, Lester S, Zahra D, Mackay CR, Rischmueller M (2008) Polymorphism in the 5\u2032 regulatory region of the B-lymphocyte activating factor gene is associated with the Ro\/La autoantibody response and serum BAFF levels in primary Sjogren\u2019s syndrome. Rheumatology (Oxford) 47(9):1311\u20131316","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"1526_CR26","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/intimm\/dxh287","volume":"17","author":"M Zhang","year":"2005","unstructured":"Zhang M, Ko KH, Lam QL, Lo CK, Srivastava G, Zheng B et al (2005) Expression and function of TNF family member B cell-activating factor in the development of autoimmune arthritis. Int Immunol 17(8):1081\u20131092","journal-title":"Int Immunol"},{"issue":"2","key":"1526_CR27","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4049\/jimmunol.173.2.807","volume":"173","author":"LG Ng","year":"2004","unstructured":"Ng LG, Sutherland AP, Newton R, Qian F, Cachero TG, Scott ML et al (2004) B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol 173(2):807\u2013817","journal-title":"J Immunol"},{"issue":"3","key":"1526_CR28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/intimm\/dxh043","volume":"16","author":"B Huard","year":"2004","unstructured":"Huard B, Arlettaz L, Ambrose C, Kindler V, Mauri D, Roosnek E et al (2004) BAFF production by antigen-presenting cells provides T cell co-stimulation. Int Immunol 16(3):467\u2013475","journal-title":"Int Immunol"},{"issue":"3 Suppl 49","key":"1526_CR29","first-page":"S112","volume":"26","author":"E Csernok","year":"2008","unstructured":"Csernok E, Holle JU, Gross WL (2008) Proteinase 3, protease-activated receptor-2 and interleukin-32: linking innate and autoimmunity in Wegener\u2019s granulomatosis. Clin Exp Rheumatol 26(3 Suppl 49):S112\u2013S117","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"1526_CR30","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/rheumatology\/ken202","volume":"47","author":"A Mueller","year":"2008","unstructured":"Mueller A, Holl-Ulrich K, Lamprecht P, Gross WL (2008) Germinal centre-like structures in Wegener\u2019s granuloma: the morphological basis for autoimmunity? Rheumatology (Oxford) 47(8):1111\u20131113","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"1526_CR31","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.4049\/jimmunol.160.7.3602","volume":"160","author":"BR Ludviksson","year":"1998","unstructured":"Ludviksson BR, Sneller MC, Chua KS, Talar-Williams C, Langford CA, Ehrhardt RO et al (1998) Active Wegener\u2019s granulomatosis is associated with HLA-DR\u2009+\u2009CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. J Immunol 160(7):3602\u20133609","journal-title":"J Immunol"},{"issue":"9","key":"1526_CR32","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.4049\/jimmunol.174.9.5537","volume":"174","author":"AP Sutherland","year":"2005","unstructured":"Sutherland AP, Ng LG, Fletcher CA, Shum B, Newton RA, Grey ST et al (2005) BAFF augments certain Th1-associated inflammatory responses. J Immunol 174(9):5537\u20135544","journal-title":"J Immunol"},{"issue":"4","key":"1526_CR33","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/art.22458","volume":"56","author":"C Daridon","year":"2007","unstructured":"Daridon C, Devauchelle V, Hutin P, Le BR, Martins-Carvalho C, Bendaoud B et al (2007) Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjogren\u2019s syndrome. Arthritis Rheum 56(4):1134\u20131144","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1526_CR34","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.clim.2005.06.016","volume":"117","author":"P Szodoray","year":"2005","unstructured":"Szodoray P, Alex P, Jonsson MV, Knowlton N, Dozmorov I, Nakken B et al (2005) Distinct profiles of Sjogren\u2019s syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF. Clin Immunol 117(2):168\u2013176","journal-title":"Clin Immunol"},{"issue":"5","key":"1526_CR35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/03009740701286615","volume":"36","author":"K Nakajima","year":"2007","unstructured":"Nakajima K, Itoh K, Nagatani K, Okawa-Takatsuji M, Fujii T, Kuroki H et al (2007) Expression of BAFF and BAFF-R in the synovial tissue of patients with rheumatoid arthritis. Scand J Rheumatol 36(5):365\u2013372","journal-title":"Scand J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1526-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-010-1526-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1526-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T19:31:53Z","timestamp":1685647913000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-010-1526-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,28]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["1526"],"URL":"https:\/\/doi.org\/10.1007\/s10067-010-1526-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,28]]}}}